Kardigan

Drug Discovery · South San Francisco, CA · Founded 2023 · Privately Held (backing)

Operator of a heart health company intended to modernize cardiovascular drug development. Kardigan is based in South San Francisco, CA and was founded in 2023. It is valued at about $646 million as of Oct 2026, set by institutional fund marks. It has raised $554 million across 1 recorded round; the latest was a $254 million Series B in Oct 2025.

PMV mark · valuation
$646.0M
Oct 2026
Priced at
—
Total raised
$554.0M
Last round
Early Stage VC (Series B)
Oct 2025

Who backs Kardigan?

7 investors
InvestorType
Fidelity Management & Research CompanyAsset manager
ARCH Venture PartnersVenture capital
T. Rowe Price Group—
Perceptive AdvisorsHedge fund
Sequoia HeritageAsset manager
HRTG Partners—
NexTech Systems (Florida)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kardigan investors

7 investors are on record for Kardigan, including Fidelity Management & Research Company, ARCH Venture Partners, T. Rowe Price Group and Perceptive Advisors. The Series B in Oct 2025 drew 3 investors.

Free account
More of Kardigan with a free account
  • ·Watch Kardigan: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Kardigan in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View